Duba tsatso na Sclerosis da yawa

{{databox}}

'''Sclerosis da yawa''' ('''MS''') cuta ce mai lalata jini wanda a cikinsa ya lalace murfin jijiyoyi a cikin kwakwalwa da kashin baya.<ref name="NIH2015">{{cite web|title=NINDS Multiple Sclerosis Information Page|url=http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_sclerosis.htm|website=National Institute of Neurological Disorders and Stroke|access-date=6 March 2016|date=19 November 2015|url-status=dead|archive-url=https://web.archive.org/web/20160213025406/http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_sclerosis.htm|archive-date=13 February 2016}}</ref> Wannan lalacewa yana rushe ikon sassan tsarin juyayi don watsa sigina, wanda ke haifar da nau'o'in alamu da alamu, ciki har da kuma matsalolin jiki, tunani, da kuma wasu lokuta na tabin hankali.<ref name="pmid18970977">{{cite journal | vauthors = Compston A, Coles A |author1-link=Alastair Compston | title = Multiple sclerosis | journal = Lancet | volume = 372 | issue = 9648 | pages = 1502–17 | date = October 2008 | pmid = 18970977 | doi = 10.1016/S0140-6736(08)61620-7 }}</ref><ref name="pmid11955556">{{cite journal|vauthors=Compston A, Coles A|title=Multiple sclerosis|journal=Lancet|volume=359|issue=9313|pages=1221–31|date=April 2002|pmid=11955556|doi=10.1016/S0140-6736(02)08220-X}}</ref><ref>{{cite book|title=Bradley's neurology in clinical practice.|year=2012|publisher=Elsevier/Saunders|location=Philadelphia, PA|isbn=978-1-4377-0434-1|edition=6th|vauthors=Murray ED, Buttner EA, Price BH|veditors=Daroff R, Fenichel G, Jankovic J, Mazziotta J|chapter=Depression and Psychosis in Neurological Practice}}</ref> Takamaiman bayyanar cututtuka na iya haɗawa da hangen nesa biyu, makanta a cikin ido ɗaya, raunin tsoka da matsala tare da jin daɗi ko daidaitawa.<ref name="NIH2015" /> MS yana ɗaukar nau'o'i da yawa, tare da sababbin alamu ko dai suna faruwa a cikin keɓantattun hare-hare (saukan sake dawowa) ko haɓakawa na tsawon lokaci (sifofin ci gaba).<ref name="pmid8780061">{{cite journal|vauthors=Lublin FD, Reingold SC|author1-link=Fred D. Lublin|title=Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis|journal=Neurology|volume=46|issue=4|pages=907–11|date=April 1996|pmid=8780061|doi=10.1212/WNL.46.4.907}}</ref> Tsakanin hare-hare, bayyanar cututtuka na iya ɓacewa gaba ɗaya; duk da haka, matsalolin jijiyoyi na dindindin sukan kasance sau da yawa, musamman yayin da cutar ta ci gaba.<ref name="autogen1">{{cite journal | vauthors = Lublin FD, Reingold SC | author1-link=Fred D. Lublin | title = Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis | journal = Neurology | volume = 46 | issue = 4 | pages = 907–11 | date = April 1996 | pmid = 8780061 | doi = 10.1212/WNL.46.4.907 }}</ref>

Duk da yake ba a san dalilin ba ana tunanin tsarin da ke ciki ko dai lalacewa ta hanyar tsarin rigakafi ko gazawar sel masu samar da myelin.<ref name="Nak2012">{{cite journal | vauthors = Nakahara J, Maeda M, Aiso S, Suzuki N | title = Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy | journal = Clinical Reviews in Allergy & Immunology | volume = 42 | issue = 1 | pages = 26–34 | date = February 2012 | pmid = 22189514 | doi = 10.1007/s12016-011-8287-6 }}</ref> Abubuwan da aka kawo na wannan sun haɗa da kwayoyin halitta da abubuwan muhalli waɗanda kamuwa da cuta ke haifar da su.<ref name="autogen2">{{cite journal | vauthors = Compston A, Coles A | title = Multiple sclerosis | journal = Lancet | volume = 359 | issue = 9313 | pages = 1221–31 | date = April 2002 | pmid = 11955556 | doi = 10.1016/S0140-6736(02)08220-X }}</ref><ref name="pmid17444504">{{cite journal|vauthors=Ascherio A, Munger KL|title=Environmental risk factors for multiple sclerosis. Part I: the role of infection|journal=Annals of Neurology|volume=61|issue=4|pages=288–99|date=April 2007|pmid=17444504|doi=10.1002/ana.21117}}</ref> Yawancin lokaci ana bincikar MS bisa ga alamu da alamun bayyanar da sakamakon goyan bayan gwaje-gwajen likita.<ref name="Tsang2011">{{cite journal | vauthors = Tsang BK, Macdonell R | title = Multiple sclerosis- diagnosis, management and prognosis | journal = Australian Family Physician | volume = 40 | issue = 12 | pages = 948–55 | date = December 2011 | pmid = 22146321 }}</ref>

Babu sanannen magani ga ''sclerosis'' da yawa.<ref name="NIH2015" /> Jiyya na ƙoƙarin inganta aiki bayan hari da hana sabbin hare-hare.<ref name="autogen2" /> Magungunan da ake amfani da su don magance MS, yayin da suke da inganci, na iya samun illa kuma ba a jure su da kyau ba.<ref name="NIH2015" /> Magungunan jiki na iya taimakawa tare da ikon mutane na yin aiki.<ref name="NIH2015" /> Mutane da yawa suna bin madadin jiyya, duk da rashin shaidar fa'ida.<ref name="pmid16420779">{{cite journal|vauthors=Huntley A|title=A review of the evidence for efficacy of complementary and alternative medicines in MS|journal=International MS Journal|volume=13|issue=1|pages=5–12, 4|date=January 2006|pmid=16420779}}</ref> Sakamakon dogon lokaci yana da wuyar tsinkaya; Mafi sau da yawa ana ganin sakamako mai kyau a cikin mata, waɗanda suka kamu da cutar a farkon rayuwarsu, waɗanda ke da koma baya, da waɗanda suka ɗanɗana farkon harin.<ref name="pmid8017890">{{cite journal|vauthors=Weinshenker BG|title=Natural history of multiple sclerosis|journal=Annals of Neurology|volume=36|issue=Suppl|pages=S6-11|year=1994|pmid=8017890|doi=10.1002/ana.410360704}}</ref> Tsawon rayuwa ya yi ƙasa da na al'ummar da ba a shafa ba a matsakaicin shekaru biyar zuwa goma.<ref name="pmid18970977" />

Sclerosis da yawa ita ce mafi yawan cututtuka na rigakafi da ke shafar tsarin kulawa na tsakiya.<ref name="pmid24746689">{{cite journal|vauthors=Berer K, Krishnamoorthy G|title=Microbial view of central nervous system autoimmunity|journal=FEBS Letters|volume=588|issue=22|pages=4207–13|date=November 2014|pmid=24746689|doi=10.1016/j.febslet.2014.04.007}}</ref> A cikin 2015, kimanin mutane miliyan 2.3 ne abin ya shafa a duniya, tare da adadin ya bambanta sosai a yankuna daban-daban da kuma tsakanin al'ummomi daban-daban.<ref name="GBD2015Pre">{{cite journal | author = GBD 2015 Disease and Injury Incidence and Prevalence Collaborators | title = Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | journal = Lancet | volume = 388 | issue = 10053 | pages = 1545–1602 | date = October 2016 | pmid = 27733282 | pmc = 5055577 | doi = 10.1016/S0140-6736(16)31678-6 }}</ref><ref name="Atlas2008">{{cite book|author=World Health Organization|title=Atlas: Multiple Sclerosis Resources in the World 2008|publisher=World Health Organization|location=Geneva|year=2008|pages=15–16|isbn=978-92-4-156375-8|url=http://whqlibdoc.who.int/publications/2008/9789241563758_eng.pdf|url-status=live|archive-url=https://web.archive.org/web/20131004215703/http://whqlibdoc.who.int/publications/2008/9789241563758_eng.pdf|archive-date=4 October 2013}}</ref> A wannan shekarar, kimanin mutane 18,900 ne suka mutu daga MS, daga 12,000 a 1990.<ref name="GBD2015De">{{cite journal | author = GBD 2015 Mortality and Causes of Death Collaborators | title = Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | journal = Lancet | volume = 388 | issue = 10053 | pages = 1459–1544 | date = October 2016 | pmid = 27733281 | pmc = 5388903 | doi = 10.1016/s0140-6736(16)31012-1 }}</ref><ref name="GDB2013">{{cite journal|title=Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013|journal=Lancet|volume=385|issue=9963|pages=117–71|date=January 2015|pmid=25530442|pmc=4340604|doi=10.1016/S0140-6736(14)61682-2|author1=GBD 2013 Mortality Causes of Death Collaborators}}</ref> Cutar takan fara tsakanin shekaru ashirin da hamsin kuma sau biyu sau biyu ga mata kamar na maza.<ref name="Milo2010">{{cite journal | vauthors = Milo R, Kahana E | title = Multiple sclerosis: geoepidemiology, genetics and the environment | journal = Autoimmunity Reviews | volume = 9 | issue = 5 | pages = A387-94 | date = March 2010 | pmid = 19932200 | doi = 10.1016/j.autrev.2009.11.010 }}</ref> An fara bayyana MS a cikin 1868 ta likitan ilimin likitancin Faransa Jean-Martin Charcot.<ref name="Charcot1">{{cite journal|vauthors=Clanet M|title=Jean-Martin Charcot. 1825 to 1893|journal=International MS Journal|volume=15|issue=2|pages=59–61|date=June 2008|pmid=18782501|url=http://www.msforum.net/Site/ViewPDF/ViewPDF.aspx?ArticleID=E80DC748-5048-4BD2-9393-18BCAE0A1514&doctype=Article|format=PDF|access-date=21 October 2010|archive-url=https://web.archive.org/web/20190330210130/http://www.msforum.net/Site/ViewPDF/ViewPDF.aspx?ArticleID=E80DC748-5048-4BD2-9393-18BCAE0A1514&doctype=Article|archive-date=30 March 2019|url-status=dead}}</ref> Sunan ''sclerosis da yawa'' yana nufin ɗimbin tabo mai glial (ko sclerae - ainihin plaques ko raunuka) waɗanda ke tasowa akan fararen fata na kwakwalwa da kashin baya.<ref name="Charcot1" /> Sabbin jiyya da hanyoyin ganowa suna ƙarƙashin haɓakawa.<ref name="pmid19597083">{{cite journal|vauthors=Cohen JA|title=Emerging therapies for relapsing multiple sclerosis|journal=Archives of Neurology|volume=66|issue=7|pages=821–8|date=July 2009|pmid=19597083|doi=10.1001/archneurol.2009.104|doi-access=free}}</ref>
[[File:En.Wikipedia-VideoWiki-Multiple_sclerosis.webm|thumbtime=1:30|thumb|Takaitaccen bidiyon jagora (rubutun)]]

== Manazarta ==
[[Category:Translated from MDWiki]]